natgillin/translations-raw huggingface dataset:
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals is a vaccine that is given by injection. 
Prepandemično cepivo proti gripi (H5N1) (z delci virionov, inaktivirano, z adjuvansom) Glaxosmithkline Biologicals je cepivo, ki se daje z injiciranjem.
The CHMP decided that the benefits of Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals are greater than its risks for active immunisation against H5N1 subtype of influenza A virus. 
Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi prepandemičnega cepiva proti gripi (H5N1) (z delci virionov, inaktiviranega, z adjuvansom) Glaxosmithkline Biologicals pri aktivni imunizaciji proti podtipu H5N1 virusa gripe A večje od z njim povezanih tveganj.
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals is a ‘prepandemic' vaccine. 
Cepivo proti gripi (H5N1) (z delci virusa, inaktivirano, z adjuvansom) GlaxoSmithKline Biologicals je „prepandemično“ cepivo.
Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals is a vaccine for use in adults to protect against flu caused by the H5N1 strain of the influenza A virus. 
Prepandemično cepivo proti gripi (H5N1) (z delci virionov, inaktivirano, z adjuvansom) Glaxosmithkline Biologicals je cepivo, ki se uporablja za cepljenje odraslih proti gripi, ki jo povzroča sev H5N1 virusa gripe A. Cepivo se daje le v skladu z uradnimi priporočili.
Very rare, not known 
Zelo redki, neznani*
• Adults and older people 
• Odrasli in starostniki
MARKETING AUTHORISATION NUMBER(S) EU/1/09/532/001 - 007 
ŠTEVILKA(E) DOVOLJENJA (DOVOLJENJ) ZA PROMET EU/1/09/532/001 - 007
• If you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na klopidogrel ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
Their frequency is defined using the following conventions: common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Njihova pogostnost je navedena upoštevaje naslednji dogovor: pogosti (≥ 1/100, < 1/10), občasni (≥ 1/1.000, < 1/100), redki (≥ 1/10.000, < 1/1.000), zelo redki (< 1/10.000), neznani (ni mogoče oceniti iz razpoložljivih podatkov).
Some other medicines may influence the use of Clopidogrel Acino or vice versa. 
Nekatera druga zdravila lahko vplivajo na uporabo zdravila Klopidogrel Acino in obratno.
Date of latest renewal: 21 march 2014 
Datum prve odobritve: 28 julij 2009 Datum zadnjega podaljšanja: 20 marca 2014
You should take Clopidogrel Acino for as long as your doctor continues to prescribe it. 
Zdravilo Klopidogrel Acino morate jemati, vse dokler vam ga vaš zdravnik predpisuje.
- a planned surgery (including dental) in the next seven days. 
nedaven kirurški poseg (vključno na zobeh) načrtovan kirurški poseg (vključno na zobeh) v naslednjih 7 dneh
14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 50 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets 
14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 50 filmsko obloženih tablet 84 filmsko obloženih tablet 90 filmsko obloženih tablet 100 filmsko obloženih tablet
Each film-coated tablet contains 3.80 mg of hydrogenated castor oil. 
Ena filmsko obložena tableta vsebuje 3,80 mg hidrogeniranega ricinusovega olja.
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. 
Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila : http://www.ema.europa.eu.
You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Clopidogrel and acetylsalicylic acid for this condition. 
Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Clopidogrel Acino in acetilsalicilne kisline.
Do not use Clopidogrel Acino if you notice any visible sign of damage of blister or film-coated tablets. 
Ne uporabljajte tega zdravila , če opazite vidne znake poškodovanja pretisnega omota ali filmsko obloženih tablet.
If you suffer from severe liver disease. 
• če imate hudo jetrno obolenje.
What Clopidogrel Acino is and what it is used for What you need to know before you take Clopidogrel Acino 
Kaj je zdravilo Klopidogrel Acino in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Klopidogrel Acino
If you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain. 
• če imate zdravstveno stanje, ki trenutno povzroča krvavitev, kot je rana na želodcu ali krvavitev v možganih.
The efficacy of clopidogrel was observed independently of the dose of ASA (75-325 mg once daily). 
Učinkovitost klopidogrela so opazili neodvisno od odmerka ASA (75 - 325 mg enkrat na dan).
Your doctor should have prescribed Clopidogrel Acino plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding. 
Zdravnik naj bi vam predpisal zdravilo Clopidogrel Acino skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
Elimination Following an oral dose of 14C-labelled clopidogrel in man, approximately 50% was excreted in the urine and approximately 46% in the faeces in the 120-hour interval after dosing. 
Izločanje Po peroralnem odmerku s 14C-označenega klopidogrela pri človeku, se ga je približno 50 % izločilo z urinom in približno 46 % z blatom v 120 urnem intervalu po odmerjanju.
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY 
A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJE B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET
If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Clopidogrel Acino. 
Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden boste vzeli Klopidogrel Acino.
If you experience prolonged bleeding when taking Clopidogrel Acino. 
Če doživite podaljšanje krvavitve v času jemanja zdravila Klopidogrel Acino.
NAME OF THE MARKETING AUTHORISATION HOLDER Acino AG 
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Acino AG
If you take more Clopidogrel Acino than you should Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding. 
Če ste vzeli večji odmerek zdravila Klopidogrel Acino, kot bi smeli Zaradi povečanega tveganja krvavitve se posvetujte s svojim zdravnikom ali oddelkom najbližje bolnišnične nujne zdravniške pomoči.
What you need to know before you take Clopidogrel Acino 
Kaj morate vedeti, preden boste vzeli zdravilo Klopidogrel Acino
In CURE, there was no excess in major bleeds with clopidogrel plus ASA within 7 days after coronary bypass graft surgery in patients who stopped therapy more than five days prior to surgery. 
V študiji CURE število velikih krvavitev s klopidogrelom in ASA ni bilo prekoračeno v 7 dneh po koronarni premostitveni operaciji pri bolnikih, ki so prenehali z zdravljenjem več kot 5 dni pred kirurškim posegom.
Do not take Clopidogrel Acino: 
Ne jemljite zdravila Klopidogrel Acino:
If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Clopidogrel Acino in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever. 
Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Klopidogrel Acino v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
If you forget to take a dose of Clopidogrel Acino, but remember within 12 hours of your usual time, take your tablet straight away and then take your next tablet at the usual time. 
Če ste pozabili vzeti zdravilo Klopidogrel Acino Če pozabite vzeti odmerek zdravila Klopidogrel Acino in se nanj spomnite do 12 ur po ustaljenem času, takoj vzemite tableto in nato vzemite naslednjo tableto spet ob ustaljenem času jemanja.
Then, the recommended dose is one 75 mg tablet of Clopidogrel Acino per day as described above. 
Nato je priporočeni odmerek ena 75-mg tableta zdravila Klopidogrel Acino na dan, kot je opisano zgoraj.
• if you have had an allergy or reaction to any medicine used to treat your disease. 
• če imate ledvične ali jetrne bolezni • če ste imeli alergijo ali alergijsko reakcijo na katero koli zdravilo, ki ste ga jemali
- a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, 
krvna motnja, zaradi katere ste bolj nagnjeni k notranji krvavitvi (krvavitev v tkivih,
Clopidogrel Acino with food and drink Clopidogrel Acino may be taken with or without food. 
Zdravilo Klopidogrel Acino skupaj s hrano in pijačo Zdravilo Klopidogrel Acino lahko jemljete s hrano ali brez nje.
New cardiovascular events (primary endpoint) were prevented, with relative risk reductions of 22% (CI: 8.6, 33.4), 32% (CI: 12.8, 46.4), 4% (CI: -26.9, 26.7), 6% (CI: -33.5, 34.3) and 14% (CI: -31.6, 44.2), during the 0-1, 1-3, 3-6, 6-9 and 9-12 month study intervals, respectively. 
Nove srčnožilne dogodke (primarni opazovani dogodek) so preprečili z zmanjšanjem relativnega tveganja: 22 % (IZ: 8,6, 33,4), 32 % (IZ: 12,8, 46,4), 4 % (IZ: -26,9, 26,7), 6 % (IZ: -33,5, 34,3) in 14 % (IZ: -31,6, 44,2) tekom 0 - 1, 1 - 3, 3 - 6, 6 - 9 oziroma 9 - 12 mesečnimi intervali študije.
If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel Acino. 
Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta, preden vzamete zdravilo Klopidogrel Acino.
You should also be given acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever as well as to prevent blood clotting) by your doctor. 
Zdravnik vam bo moral predpisati tudi acetilsalicilno kislino (učinkovina, ki je prisotna v številnih zdravilih proti bolečinam in za zniževanje zvišane telesne temperature, kakor tudi za preprečevanje strjevanja krvi).
• You should also tell your doctor immediately if you develop a medical condition (also known as Thrombotic Thrombocytopenic Purpura or TTP) that includes fever and bruising under the skin that may appear as red pinpoint dots, with or without unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice) (see section 4). 
• morate takoj povedati zdravniku, če razvijete bolezensko stanje (znano tudi kot trombotična trombocitopenična purpura ali TTP) z zvišano telesno temperaturo in modricami pod kožo, ki se lahko pojavijo kot drobne rdeče pike, z ali brez nerazložljive hude utrujenosti, zmedenosti, porumenele kože ali oči (zlatenica) (glejte poglavje 4).
If you become pregnant while taking Clopidogrel Acino, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant. 
Če med zdravljenjem z zdravilom Klopidogrel Acino zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
What Clopidogrel Acino is and what it is used for 
Kaj je zdravilo Klopidogrel Acino in za kaj ga uporabljamo
Clopidogrel Acino is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). 
Klopidogrel Acino jemljejo odrasli za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
Driving and using machines Clopidogrel Acino is unlikely to affect your ability to drive or to use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel Acino vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. 
Druga zdravila in zdravilo Klopidogrel Acino Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli zdravilo, tudi če ste ga dobili brez recepta.
The recommended dose, including for patients with a condition called ‘atrial fibrillation' (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Acino per day to be taken orally with or without food, and at the same time each day. 
Priporočeni odmerek, vključno za bolnike, ki imajo bolezensko stanje, imenovano "atrijska fibrilacija" (nepravilen srčni utrip), je ena 75 mg tableta zdravila Klopidogrel Acino na dan, ki jo lahko vzamete s hrano ali brez nje; odmerek morate jemati vsak dan ob istem času.
The use of clopidogrel in CURE was associated with a decrease in the need of thrombolytic therapy (RRR = 43.3%; CI: 24.3%, 57.5%) and GPIIb/IIIa inhibitors (RRR = 18.2%; CI: 6.5%, 28.3%). 
Uporaba klopidogrela v CURE je bila povezana z zmanjšano potrebo po zdravljenju s trombolitiki (zmanjšanje RT=43,3 %; IZ: 24,3 %, 57,5 %) in inhibitorji glikoproteinov IIb/IIIa (zmanjšanje RT=18,2 %; IZ: 6,5 %, 28,3 %).
You have an irregular heartbeat, a condition called ‘atrial fibrillation', and you cannot take medicines known as ‘oral anticoagulants' (vitamin K antagonists) which prevent new clots from forming and prevent existing clots from growing. 
- imate neredno bitje srca, motnjo, imenovano "atrijska fibrilacija", in ne morete prejemati zdravil, imenovanih "peroralni antikoagulanti" (antagonisti vitamina K), ki preprečujejo nastajanje novih krvnih strdkov in preprečujejo rast obstoječih krvnih strdkov.
Clopidogrel Acino contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products. 
Klopidogrel Acino vsebuje klopidogrel in spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
The most common side effect reported with Clopidogrel Acino is bleeding. 
Najpogostejši neželeni učinek, o katerem so poročali s klopidogrelom, je krvavitev.
• Hypersensitivity to the active substance or to any of the excipients listed in section 2 or section 
• Preobčutljivost za zdravilno učinkovino ali katerokoli pomožno snov, navedeno v
Rare side effect (may affect up to 1 in 1000 people): Vertigo, enlarged breasts in males. 
- Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov): Vrtoglavica, povečanje prsi pri moških.
White to off-white, marbled, round and biconvex film-coated tablets. 
filmsko obložena tableta Bele do belkaste, marmorirane, okrogle, bikonveksne filmsko obložene tablete.
Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes intaste of food. 
Zlatenica, huda bolečina v trebuhu z ali brez bolečine v hrbtu, zvišana telesna temperatura, težave pri dihanju, ki so včasih povezane s kašljem, splošne alergijske reakcije (na primer, splošni občutek toplote z nenadnim nelagodjem do nezavesti), oteklina v ustih, mehurji na koži, kožna alergija, vnetje v ustih (stomatitis), znižanje krvnega tlaka, zmedenost, halucinacije, bolečine v sklepih, bolečine v mišicah, motnje v okušanju hrane.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Serum sickness, anaphylactoid reactions, cross-reactive drug hypersensitivity among thienopyridines (such as ticlopidine, prasugrel) (see section 4.4)* 
Serumska bolezen, anafilaktoidne reakcije, navzkrižna preobčutljivost med tienopiridini (kot sta tiklopidin in prasugrel) (glejte poglavje 4.4)*
ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy. 
akutni miokardni infarkt z elevacijo ST spojnice v kombinaciji z ASA pri bolnikih, ki se zdravijo z zdravili in so primerni za trombolitično zdravljenje.
In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with Vitamin K antagonists (VKA) and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke. 
Preprečevanje aterotrombotičnih in trombemboličnih dogodkov pri atrijski fibrilaciji Pri odraslih bolnikih z atrijsko fibrilacijo, ki imajo vsaj en dejavnik tveganja za žilne dogodke in ki niso primerni za zdravljenje z antagonisti vitamina K (VKA) ter imajo majhno tveganje za krvavitev, je klopidogrel v kombinaciji z ASA indiciran za preprečevanje aterotrombotičnih in trombemboličnih dogodkov, vključno z možgansko kapjo.
Patients were randomised to clopidogrel 75 mg/day or ASA 325 mg/day, and were followed for 1 to 3 years. 
75 mg/dan ali ASA 325 mg/dan, spremljali so jih od 1 do 3 let.
In patients with atrial fibrillation, clopidogrel should be given as a single daily dose of 75 mg. ASA (75-100 mg daily) should be initiated and continued in combination with clopidogrel (see 
Bolniki z atrijsko fibrilacijo morajo klopidogrel dobivati v enem dnevnem odmerku 75 mg. ASA (75-100 mg na dan) je treba uvesti in nadaljevati v kombinaciji s klopidogrelom (glejte poglavje 5.1).
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus 
Bulozen dermatitis (toksična epidermalna nekroliza, StevensJohnsonov sindrom, multiformni eritem, akutna generalizirana eksantemska pustuloza (AGEP)), angioedem, z zdravili povzročen sindrom preobčutljivosti (sindrom DIHS, DrugInduced Hypersensitivity Syndrome), kožni izpuščaj z eozinofilijo in sistemskimi simptomi, kot posledica zdravljenja z zdravilom (sindrom DRESS, Drug Rash with Eosinophilia and Systemic Symptoms), eritematozen ali eksfoliativen izpuščaj,
As with other antiplatelet agents, clopidogrel should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions and in patients receiving treatment with ASA, heparin, glycoprotein IIb/IIIa inhibitors or nonsteroidal anti-inflammatory drugs (NSAIDs) including Cox-2 inhibitors, or selective serotonin reuptake inhibitors (SSRIs), or other medicinal products associated with bleeding risk such as pentoxifylline (see section 4.5). 
Kot pri drugih antitrombotikih, moramo klopidogrel uporabljati previdno pri bolnikih s tveganjem za povečano krvavitev zaradi poškodbe, kirurškega posega ali drugih patoloških stanj in pri bolnikih, ki so na zdravljenju z ASA, heparinom, zaviralci glikoproteina IIb/IIIa ali nesteroidnimi protivnetnimi zdravili (NSAIDs) vključno z zaviralci COX-2, ali s selektivnimi zaviralci privzema serotonina (SSRI), ali z drugimi zdravili, ki so povezana s tveganjem za krvavitve, kot je pentoksifilin (glejte poglavje 4.5).
If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel Acino (4 tablets of 75 mg) once at the start of treatment. 
Če ste imeli hudo bolečino v prsih (nestabilna angina pektoris ali srčna kap), vam lahko zdravnik na začetku zdravljenja da 300 mg zdravila Klopidogrel Acino v enkratnem odmerku (štiri 75-mg tablete).
Thrombotic thrombocytopenic purpura (TTP) (see section 4.4), aplastic anaemia, pancytopenia, agranulocytosis, severe thrombocytopenia, acquired haemophilia A, granulocytopenia, anaemia 
Trombotična trombocitopenična purpura (TTP) (glejte poglavje 4.4), aplastična anemija, pancitopenija, agranulocitoza, huda trombocitopenija, pridobljena hemofilija A, granulocitopenija, anemija
Very rare side effects (may affect up to 1 in 10,000 people): 
- Zelo redki neželeni učinki (pojavijo se lahko pri največ 1 od 10.000 bolnikov):
Uncommon side effects (may affect up to 1 in 100 people): 
- Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov):
Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). 
• bolnikih z akutnim koronarnim sindromom: akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca), vključno z bolniki, katerim je bil vstavljen stent po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilno kislino (ASA - acetylsalicylic acid).
For more than 12 hours: patients should take the next dose at the regular scheduled time 
- če je zamuda več kot 12 ur: bolnik naj naslednji odmerek vzame ob pravem času;
What Clopidogrel Acino looks like and contents of the pack 
Izgled zdravila Klopidogrel Acino in vsebina pakiranja
Clopidogrel Acino 75 mg 
PODATKI V BRAILLOVI PISAVI Klopidogrel Acino 75 mg
Excipients Clopidogrel Acino contains hydrogenated castor oil which may cause stomach upset and diarrhoea. 
Pomožne snovi Klopidogrel Acino vsebuje hidrogenirano ricinusovo olje, ki lahko razdraži želodec in povzroči drisko.
NAME OF THE MEDICINAL PRODUCT Clopidogrel Acino 75 mg film-coated tablets 
IME ZDRAVILA Klopidogrel Acino 75 mg filmsko obložene tablete
The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p=0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG). 
Delež bolnikov s primarnim opazovanim dogodkom [srčno-žilna (SŽ) smrt, miokardni infarkt (MI) ali kap] je bil 582 (9,3 %) v skupini, zdravljeni s klopidogrelom, in 719 (11,4 %) v skupini, ki je prejemala placebo, to je 20 % zmanjšanje relativnega tveganja (95 % IZ od 10 % - 28 %; p=0,00009) v skupini, zdravljeni s klopidogrelom (17 % zmanjšanje relativnega tveganja, če so bili bolniki zdravljeni konzervativno, 29 % kadar je bila izvedena perkutana transluminalna koronarna angioplastika (PTCA) z ali brez stenta in 10 %, če je bila izvedena premostitvena operacija koronarnih arterij (CABG)).